Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2019-12-02
2020-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Intact and Disrupted Milk Fat Globule Membrane on Postprandial Metabolic Response to High-fat Dairy in Healthy Individuals
NCT06340412
Saturated Fatty Acids and HDL Metabolism
NCT02835651
Role of Milk Fat Globule Membranes in Dairy Foods: Health Effects in Humans
NCT01767077
Postprandial Effects of Milk and Milk Constituents
NCT00917878
Full-fat Dairy Products, Body Weight Control and Metabolic Health
NCT05417347
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objectives: The primary objective of this study is to determine the effect of three different fat blends on underlying mechanistic and immune responses in the circulation. The secondary objectives of this study are: 1) to examine the effects of the three different fat blends on postprandial triglyceride concentration and other cardio-metabolic markers in the circulation, 2) to investigate the effect of the three different fat blends on postprandial feelings of hunger and satiety, and 3) to investigate how comparable cytokine measurements are in blood samples obtained via a catheter cannula compared to cytokine measurements in dried blood spots obtained via a finger prick.
Study design: The POEMI Study is a double-blind randomized cross-over acute intervention study in which each research subject will visit the university on three separate occasions with a wash-out period of at least one week. At each visit the research subject will undergo one of the three dietary lipid challenge tests (a shake) in a randomized order. On each study day research subjects will be asked to clock in 30 minutes prior to the first data collection points and a catheter cannula will be inserted in a antecubital vein. After the 30 minute rest, blood will be drawn from the catheter cannula and via a finger prick (baseline measurements, t0). After the baseline measurements, the research subjects will have to consume the shake within a time frame of 10 minutes. Blood is again drawn from the catheter cannula at t= 1, 2, 3, 4, 5, 6, 7, and 8 hours after consumption, with an additional finger prick at t=6. A questionnaire on hunger and satiety feelings will be taken after every blood draw.
Study population: The base population will consist of 40 healthy men and women with a BMI ranging from 22 to 27 kg/m2, aged 40 to 70 years old, selected from the surroundings of Wageningen through the mailing list for potential study research subjects of the division of Human Nutrition and health of Wageningen University. If needed, additional recruitment of research subjects will take place by flyers and posters, or advertisements in local newspapers.
Intervention: The dietary lipid challenge tests will be provided in the form of a liquid shake (0.6 L). Each shake will contain 95 gram of fat. The three types of fat that will be tested include: a) 100% vegetable fat blend, b) 100% Anhydrous milk fat (AMF), c) 100% cream (AMF + milk fat globular membranes).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
V-A-C
Order of administration:
1. 100% vegetable fat blend
2. 100% Anhydrous Milk Fat (AMF)
3. 100% Cream (AMF + milk fat globular membranes)
100% vegetable blend
Dietary lipid challenge test: 600 ml skimmed milk plus 95 gram of vegetable fat blend.
100% AMF
Dietary lipid challenge test: 600 ml skimmed milk plus 95 gram of anhydrous milk fat.
100% cream
Dietary lipid challenge test: 600 ml skimmed milk plus 95 gram of anhydrous milk fat plus milk fat globular membranes.
V-C-A
Order of administration:
1. 100% vegetable fat blend
2. 100% Cream (AMF + milk fat globular membranes)
3. 100% Anhydrous Milk Fat (AMF)
100% vegetable blend
Dietary lipid challenge test: 600 ml skimmed milk plus 95 gram of vegetable fat blend.
100% AMF
Dietary lipid challenge test: 600 ml skimmed milk plus 95 gram of anhydrous milk fat.
100% cream
Dietary lipid challenge test: 600 ml skimmed milk plus 95 gram of anhydrous milk fat plus milk fat globular membranes.
A-V-C
Order of administration:
1. 100% Anhydrous Milk Fat (AMF)
2. 100% vegetable fat blend
3. 100% Cream (AMF + milk fat globular membranes)
100% vegetable blend
Dietary lipid challenge test: 600 ml skimmed milk plus 95 gram of vegetable fat blend.
100% AMF
Dietary lipid challenge test: 600 ml skimmed milk plus 95 gram of anhydrous milk fat.
100% cream
Dietary lipid challenge test: 600 ml skimmed milk plus 95 gram of anhydrous milk fat plus milk fat globular membranes.
A-C-V
Order of administration:
1. 100% Anhydrous Milk Fat (AMF)
2. 100% Cream (AMF + milk fat globular membranes)
3. 100% vegetable fat blend
100% vegetable blend
Dietary lipid challenge test: 600 ml skimmed milk plus 95 gram of vegetable fat blend.
100% AMF
Dietary lipid challenge test: 600 ml skimmed milk plus 95 gram of anhydrous milk fat.
100% cream
Dietary lipid challenge test: 600 ml skimmed milk plus 95 gram of anhydrous milk fat plus milk fat globular membranes.
C-A-V
Order of administration:
1. 100% Cream (AMF + milk fat globular membranes)
2. 100% Anhydrous Milk Fat (AMF)
3. 100% vegetable fat blend
100% vegetable blend
Dietary lipid challenge test: 600 ml skimmed milk plus 95 gram of vegetable fat blend.
100% AMF
Dietary lipid challenge test: 600 ml skimmed milk plus 95 gram of anhydrous milk fat.
100% cream
Dietary lipid challenge test: 600 ml skimmed milk plus 95 gram of anhydrous milk fat plus milk fat globular membranes.
C-V-A
Order of administration:
1. 100% Cream (AMF + milk fat globular membranes)
2. 100% vegetable fat blend
3. 100% Anhydrous Milk Fat (AMF)
100% vegetable blend
Dietary lipid challenge test: 600 ml skimmed milk plus 95 gram of vegetable fat blend.
100% AMF
Dietary lipid challenge test: 600 ml skimmed milk plus 95 gram of anhydrous milk fat.
100% cream
Dietary lipid challenge test: 600 ml skimmed milk plus 95 gram of anhydrous milk fat plus milk fat globular membranes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
100% vegetable blend
Dietary lipid challenge test: 600 ml skimmed milk plus 95 gram of vegetable fat blend.
100% AMF
Dietary lipid challenge test: 600 ml skimmed milk plus 95 gram of anhydrous milk fat.
100% cream
Dietary lipid challenge test: 600 ml skimmed milk plus 95 gram of anhydrous milk fat plus milk fat globular membranes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 40-70y at the time of recruitment
* BMI of 22-27 kg/m2
* Having a Hb value above 8.4 (men) or 7.4 (women) mmol/L (will be checked at the screening visit)
* Having veins suitable for blood sampling via a catheter cannula (judged by study nurse/ medical doctor)
* Having a general practitioner
* Signed informed consent
Exclusion Criteria
* History of gastro-intestinal surgery or having (serious) gastro-intestinal complaints
* Renal or hepatic malfunctioning (pre-diagnosis or determined based on ALAT, ASAT and creatinine values)
* Use of medication that may influence the study results, such as laxatives, stomach protectors and drugs that can affect intestinal motility.
* Donated or intend to donate blood from 2 months before the study until the end of the study
* Reported slimming, medically prescribed or vegan diet
* Unstable body weight (weight gain or loss \>5 kg in the past three months)
* Current smokers
* Alcohol on average: more than 2 consumptions/day or more than 14 consumptions/week
* Pregnant, lactating or wishing to become pregnant in the period of the study (self-reported)
* Use of illicit drugs
* Food allergies for products that the investigators use in the study
* Participation in another clinical trial at the same time, or in the month preceding the start of this study
* Inability to understand study information and/or communicate with staff
* Members of the research team
* Working, or doing an internship or thesis at the division "Human Nutrition and Health", Wageningen University
40 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Friesland Campina
UNKNOWN
Wageningen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lydia A. Afman
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lydia Afman, PhD
Role: PRINCIPAL_INVESTIGATOR
Wageningen University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wageningen University, Division of Human Nutrition
Wageningen, Gelderland, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL69492.081.19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.